Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Retained Earnings (2018 - 2025)

Inventiva (IVEVF) posted Retained Earnings of -$412.2 million for Q4 2025, down 107.06% on a QoQ basis from -$199.1 million in Q2 2025, and down 109.42% year-over-year from $4.4 billion in Q4 2024.

Analysis

Inventiva (IVEVF) Retained Earnings (2018 - 2025) Analysis & Trends

Inventiva has reported Retained Earnings for 8 years, with the latest figure at -$412.2 million in Q4 2025.

  • On a quarterly basis, Retained Earnings fell 109.42% year-over-year to -$412.2 million in Q4 2025; TTM through Dec 2025 was -$412.2 million, a 109.42% decrease from a year earlier, with the FY2025 full-year figure at -$412.2 million, down 109.42% from the prior year.
  • Retained Earnings was -$412.2 million for Q4 2025 at Inventiva, down from -$199.1 million in the prior quarter.
  • The five-year high for Retained Earnings was -$1.6 million in Q2 2024, with the low at -$412.2 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$111.1 million, with a median of -$56.1 million recorded in 2021.
  • The sharpest annual moves came in 2022 and 2025: Retained Earnings climbed 2.48% in 2022, then sank 12151.6% in 2025.
  • Over 5 years, Retained Earnings stood at -$56.8 million in 2021, then increased by 2.48% to -$55.4 million in 2022, then tumbled by 114.57% to -$118.8 million in 2023, then sank by 65.68% to -$196.8 million in 2024, then plunged by 109.42% to -$412.2 million in 2025.
  • The last three Retained Earnings figures came in at -$412.2 million (Q4 2025), -$199.1 million (Q2 2025), and -$196.8 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 646.71 Bn 625.95 Bn 17.26 Bn 171.67 Bn
2 AbbVie 442.22 Bn 435.65 Bn 12.70 Bn -17.33 Bn
3 Merck 366.92 Bn 359.78 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 266.90 Bn 259.21 Bn 11.24 Bn 40.86 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn 112.09 Bn
6 Sanofi 52.44 Bn 45.06 Bn 10.79 Bn -
7 Revolution Medicines 44.11 Bn 44.11 Bn - -4.00 Bn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 1.10 Bn
9 United Therapeutics 21.50 Bn 18.84 Bn 683.80 Mn 9.16 Bn
10 Inventiva 693.72 Mn 693.72 Mn - -412.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -412.23 Mn
Jun 30, 2025 -199.09 Mn
Dec 31, 2024 -196.85 Mn
Jun 30, 2024 -1.63 Mn
Dec 31, 2023 -118.81 Mn
Dec 31, 2022 -55.37 Mn
Jun 30, 2022 -31.44 Mn
Dec 31, 2021 -56.78 Mn
Jun 30, 2021 -27.86 Mn
Mar 31, 2021 -10.66 Mn
Dec 31, 2020 -40.08 Mn
Dec 31, 2019 -33.45 Mn
Dec 31, 2018 -37.68 Mn